| Add to balance / Manage account | User: | Log out |
| Prospect News home > News index > List of issuers U > Headlines for Unipharma, LLC > News item |
Unipharma disclosure statement hearing continued to Jan. 28
By Sarah Lizee
Olympia, Wash., Jan. 26 – Unipharma, LLC’s hearing on the disclosure statement for its Chapter 11 plan of liquidation has been continued to Jan. 28, according to a notice filed Tuesday with the U.S. Bankruptcy Court for the Southern District of Florida.
As previously reported, the plan provides for the appointment of a plan administrator to control and effectuate the claims reconciliation process, make distributions to holders of allowed claims and direct the wind-down, liquidation, sale or abandoning of the remaining assets of the debtors, among other things.
Under the plan, holders of other secured claims will receive payment in full in cash or receive the collateral securing their claims.
Holders of other priority claims will receive cash in full.
Holders of NHTV ULM Holdings LLC claims and pre-petition unsecured subordinated notes claims will receive their pro rata share of the liquidating trust interests, after all DIP claims are satisfied in full in cash.
Holders of general unsecured claims will receive their pro rata share of the NHTV class 5 claims distribution and liquidating trust interests, after all DIP claims are satisfied in full in cash.
Holders of intercompany claims, other subordinated claims, existing Tamarac equity interests and existing Unipharma interests will not receive or retain any property on account of their claims.
Unipharma is a Tamarac, Fla., health care packaging company serving the pharmaceutical and nutraceutical sectors in the development, manufacturing and packaging of liquid, disposable and single-dose units. The company filed bankruptcy on Dec. 7 under Chapter 11 case number 20-23348.
© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere.
For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.